KALAMAZOO, Mich., Jan. 30 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that it will conduct an Analyst Meeting on Wednesday, May 20, 2009, at 8:00 a.m. Eastern Time, in New York, New York.

Stephen P. MacMillan, President and Chief Executive Officer, will host the meeting with presentations by leaders of the Company's key business units.

A simultaneous webcast of the meeting will be available on Stryker's website at www.stryker.com via the For Investors page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial 800-884-5695 (domestic) or 617-786-2960 (international) and enter registration number 98922638.

A recording of the meeting will be available from 12:00 p.m. Eastern Time, on May 20, 2009, until 12:00 p.m. Eastern Time, on May 27, 2009. To hear this recording, dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter registration number 20013937.

Certain statements made in the presentation may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit www.stryker.com.

SOURCE Stryker Corporation
CONTACT: Katherine A. Owen, Vice President, Strategy and Investor
Relations, Stryker Corporation, +1-269-385-2600/
/Web Site: http://www.stryker.com /
(SYK)